Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Share :

NCRI

4 - 7 Oct 2009
Liverpool, United Kingdom of Great Britain and Northern Ireland

NCRI Presentation: Elements of epithelial cancer

Prof Larry Norton - Memorial Sloan-Kettering Cancer Center, New York, USA
NCRI Presentation: Elements of epithelial cancer ( Prof Larry Norton - Memorial Sloan-Kettering Cancer Center, New York, USA )
15 Dec 2009

NCRI presentation: Better clinical trials

Prof Ian F Tannock, Princess Margaret hospital and University of Toronto
NCRI presentation: Better clinical trials ( Prof Ian F Tannock, Princess Margaret hospital and University of Toronto )
8 Dec 2009

The future of early cancer diagnosis by detecting b-cell immune responses

Professor John Robertson, Professor of Surgery at the University of Nottingham, UK
The future of early cancer diagnosis by detecting b-cell immune responses ( Professor John Robertson, Professor of Surgery at the University of Nottingham, UK )
7 Dec 2009

BACR and chemo prevention work

Professor Andreas Gescher, Cancer Studies and Molecular Medicine, Leicester Royal Infirmary, UK
BACR and chemo prevention work ( Professor Andreas Gescher, Cancer Studies and Molecular Medicine, Leicester Royal Infirmary, UK )
7 Dec 2009

Non-FDG PET imaging

Dr Stefano Fanti, University of Bologna, Italy
Non-FDG PET imaging ( Dr Stefano Fanti, University of Bologna,  Italy )
2 Dec 2009

New technology allows imaging deep into tumours

Prof Peter Friedl, Radboud University Nijmegen Medical Center, Netherlands
New technology allows imaging deep into tumours ( Prof Peter Friedl, Radboud University Nijmegen Medical Center, Netherlands )
20 Nov 2009

The Darwinian view of cancer

Professor Mel Greaves, The Institute of Cancer Research, London, UK
The Darwinian view of cancer ( Professor Mel Greaves, The Institute of Cancer Research, London, UK )
20 Nov 2009

Chemo prevention for bowel cancer - the prospects and challenges

Prof Richard Logan, Clinical Epidemiology, University of Nottingham, UK
Chemo prevention for bowel cancer - the prospects and challenges ( Prof Richard Logan, Clinical Epidemiology, University of Nottingham, UK )
20 Nov 2009

Advances in the use of antibodies

Prof Martin Glennie, Director of Cancer Sciences, University of Southampton, UK
Advances in the use of antibodies ( Prof Martin Glennie, Director of Cancer Sciences, University of Southampton, UK )
20 Nov 2009

Pioneer factors – a new class of proteins

Dr Jason Carroll, Cambridge Research Institute, UK
Pioneer factors – a new class of proteins ( Dr Jason Carroll, Cambridge Research Institute, UK )
18 Nov 2009

New PET tracers

Dr. Martin Christlieb, Gray Institute for radiation oncology and biology, University of Oxford
New PET tracers ( Dr. Martin Christlieb, Gray Institute for radiation oncology and biology, University of Oxford )
18 Nov 2009

Intensity-Modulated Radiation Therapy (IMRT) for head and neck cancer patients

Dr. Chris Nutting, Radiation Oncologist, Royal Marsden Hospital, UK
Intensity-Modulated Radiation Therapy (IMRT) for head and neck cancer patients ( Dr. Chris Nutting, Radiation Oncologist, Royal Marsden Hospital, UK )
18 Nov 2009

The winner of the lifetime achievement award discusses his work

Prof Hilary Calvert, Director of Cancer Drug Discovery and Development at the UCL Cancer Institute, UK
The winner of the lifetime achievement award discusses his work ( Prof Hilary Calvert, Director of Cancer Drug Discovery and Development at the UCL Cancer Institute, UK )
18 Nov 2009

Second Malignancies , causes and prevention strategies

Prof Van Leeuwen, Cancer Epidemiology Unit, Netherlands Cancer Institute
Second Malignancies , causes and prevention strategies ( Prof  Van Leeuwen, Cancer Epidemiology Unit, Netherlands Cancer Institute )
18 Nov 2009

Video assisted thoracic surgery in lung cancer and chest reconstruction

Aman S. Coonar, Thoracic Surgery, Papworth Hospital, Cambridge, UK
Video assisted thoracic surgery in lung cancer and chest reconstruction ( Aman S. Coonar, Thoracic Surgery, Papworth Hospital, Cambridge, UK )
13 Nov 2009

Research on cell progress through mitosis

Dr Andrea Musacchio, Structural Biology Unit of the Department of Experimental Oncology, European Institute of Oncology, Milan
Research on cell progress through mitosis ( Dr Andrea Musacchio, Structural Biology Unit of the Department of Experimental Oncology, European Institute of Oncology, Milan )
10 Nov 2009

Using Molecular imaging techniques in order to identify features of the microenvironment of a tumour that can be seen non-invasively

Dr. John L. Humm, Chief of Nuclear Medicine Physics, Memorial Sloan-Kettering Cancer Center , USA
Using Molecular imaging techniques in order to identify features of the microenvironment of a tumour that can be seen non-invasively ( Dr. John L. Humm, Chief of Nuclear Medicine Physics, Memorial Sloan-Kettering Cancer Center , USA )
10 Nov 2009

Discussion on the latest research for using bisphosphonates to treat cancer metastasis

Professor Robert Coleman - Cancer Research Centre, Academic Unit of Clinical Oncology, Weston Park Hospital
Discussion on the latest research for using bisphosphonates to treat cancer metastasis ( Professor Robert Coleman - Cancer Research Centre, Academic Unit of Clinical Oncology, Weston Park Hospital )
10 Nov 2009

NCRI presentation: Difficult decisions at the end of life

Prof Ilora Finlay - Cardiff University School of Medicine, UK
NCRI presentation: Difficult decisions at the end of life ( Prof Ilora Finlay - Cardiff University School of Medicine, UK )
27 Oct 2009

National Cancer Research Institute Conference, 4th-7th October 2009

Prof Gordon McVie - European Institute of Oncology, Milan
National Cancer Research Institute Conference, 4th-7th October 2009 ( Prof Gordon McVie - European Institute of Oncology, Milan )
16 Oct 2009

The mitotic spindle and potential development for targeting novel types of interactions

Prof Ashok Venkitaraman, University of Cambridge, UK
The mitotic spindle and potential development for targeting novel types of interactions ( Prof Ashok Venkitaraman, University of Cambridge, UK )
6 Oct 2009